Neuren Pharmaceuticals Limited Stock Probability of Future Pink Sheet Price Finishing Under 12.51
| NURPF Stock | USD 12.51 0.00 0.00% |
Neuren |
Neuren Pharmaceuticals Target Price Odds to finish below 12.51
The tendency of Neuren Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 12.51 | 90 days | 12.51 | about 17.83 |
Based on a normal probability distribution, the odds of Neuren Pharmaceuticals to move below current price in 90 days from now is about 17.83 (This Neuren Pharmaceuticals Limited probability density function shows the probability of Neuren Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Neuren Pharmaceuticals has a beta of 0.39. This indicates as returns on the market go up, Neuren Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Neuren Pharmaceuticals Limited will be expected to be much smaller as well. Additionally Neuren Pharmaceuticals Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Neuren Pharmaceuticals Price Density |
| Price |
Predictive Modules for Neuren Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neuren Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuren Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuren Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Neuren Pharmaceuticals is not an exception. The market had few large corrections towards the Neuren Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neuren Pharmaceuticals Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neuren Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.32 | |
β | Beta against NYSE Composite | 0.39 | |
σ | Overall volatility | 0.97 | |
Ir | Information ratio | -0.12 |
Neuren Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neuren Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neuren Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Neuren Pharmaceuticals generated a negative expected return over the last 90 days | |
| Neuren Pharmaceuticals has high historical volatility and very poor performance | |
| Neuren Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.2 M. Net Loss for the year was (7.79 M) with loss before overhead, payroll, taxes, and interest of (6.32 M). | |
| Neuren Pharmaceuticals Limited has accumulated about 31.09 M in cash with (9.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders |
Neuren Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neuren Pink Sheet often depends not only on the future outlook of the current and potential Neuren Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuren Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 129 M |
Neuren Pharmaceuticals Technical Analysis
Neuren Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Neuren Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neuren Pharmaceuticals Limited. In general, you should focus on analyzing Neuren Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Neuren Pharmaceuticals Predictive Forecast Models
Neuren Pharmaceuticals' time-series forecasting models is one of many Neuren Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Neuren Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Neuren Pharmaceuticals
Checking the ongoing alerts about Neuren Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Neuren Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Neuren Pharmaceuticals generated a negative expected return over the last 90 days | |
| Neuren Pharmaceuticals has high historical volatility and very poor performance | |
| Neuren Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.2 M. Net Loss for the year was (7.79 M) with loss before overhead, payroll, taxes, and interest of (6.32 M). | |
| Neuren Pharmaceuticals Limited has accumulated about 31.09 M in cash with (9.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders |
Check out Neuren Pharmaceuticals Backtesting, Neuren Pharmaceuticals Valuation, Neuren Pharmaceuticals Correlation, Neuren Pharmaceuticals Hype Analysis, Neuren Pharmaceuticals Volatility, Neuren Pharmaceuticals History as well as Neuren Pharmaceuticals Performance. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Neuren Pink Sheet analysis
When running Neuren Pharmaceuticals' price analysis, check to measure Neuren Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuren Pharmaceuticals is operating at the current time. Most of Neuren Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Neuren Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuren Pharmaceuticals' price. Additionally, you may evaluate how the addition of Neuren Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |